title: A new cause of acute hepatitis: gemifloxacin.
authors: Serta
authors: S
authors: Kilincalp
authors: Murat
authors: M
authors: Deveci
authors: Sahin
authors: S
authors: Coban
authors: Omer
authors: O
authors: Basar
authors: Osman
authors: O
authors: Yuksel
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D002353:Carrier State / Q000097:blood*; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000209:etiology / Q000628:therapy; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000009:adverse effects*; D000077735:Gemifloxacin; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D008111:Liver Function Tests / Q000379:methods; D008875:Middle Aged; D009287:Naphthyridines / Q000008:administration & dosage / Q000009:adverse effects*; D012220:Rhinitis / Q000188:drug therapy* / Q000503:physiopathology; D012307:Risk Factors; D012852:Sinusitis / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D006514:Hepatitis B Surface Antigens; D009287:Naphthyridines; D000077735:Gemifloxacin